Maternus-Kliniken Aktiengesellschaft (MAK.DE) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold MAK.DE in your mock portfolio yet.
The company is currently loss-making, as indicated by negative EPS and a negative P/E ratio. This suggests structural profitability challenges rather than a one-off earnings dip. Without evidence of improving earnings trends, the financial profile points to elevated risk for equity holders.
The stock trades at €0.89, below its 200-day moving average of €1.06, indicating a prevailing downtrend. A 10.6% decline over the last month reinforces short-term negative momentum. From a technical standpoint, the setup is weak unless there is a clear reversal signal or fundamental catalyst.
Digital footprint indicators are modest and slightly deteriorating. Low web traffic and a marginal decline in YouTube subscribers point to limited and weakening online engagement. These signals are not decisive alone but are directionally negative for brand visibility and growth perception.
Overall, Maternus-Kliniken Aktiengesellschaft’s profile appears bearish at this stage. Loss-making fundamentals, a stock price trending below its long-term average, and soft alternative data collectively point to elevated risk and limited near-term upside without a clear turnaround catalyst.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started